Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

NCT01246557

Conditions
Chronic Disease, Chronic Lymphatic Leukemia, Disease Attributes, +14 more
Locations
  • Centro Médico Teknon Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital Universitari Valle Hebron Barcelona, Spain
  • Hospital Clinico Universitario de Barcelona Barcelona, Spain
View Trial Details
Completed

A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia

NCT01196013

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • National Kyusyu Cancer Center Fukuoka, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Kagoshima University Medical and Dental Hospital Kagoshima, Japan
  • Tokai University Hospital Kanagawa, Japan
View Trial Details
Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations
  • Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
  • AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
View Trial Details
Completed

Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients

NCT00086580

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Medizinische Universitatsklinik Graz Graz, Austria
  • Universitat Wien AKH, Innere Medizin I Vienna, Austria
  • University Multiprofile Hospital for Active Treatment Dr. Georgi Stranski Pleven, Bulgaria
View all 48 locations
View Trial Details
Completed

Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia

NCT00328198

Conditions
B-Cell Chronic Lymphocytic Leukemia (B-CLL), Bronchial Diseases, Bronchiolitis, +25 more
Locations
  • Moores Cancer Center La Jolla, California, United States
  • Wilshire Oncology Medical Group La Verne, California, United States
  • University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers Colorado Springs, Colorado, United States
View all 21 locations
View Trial Details
Completed

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

NCT00438958

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
Locations
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
  • Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada
View all 16 locations
View Trial Details

Related conditions